Status:
COMPLETED
Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population
Lead Sponsor:
University of California, San Francisco
Conditions:
Severe Combined Immunodeficiency
T Cell Lymphocytopenia
Eligibility:
All Genders
1-30 years
Brief Summary
The goal of the proposed research is to establish the validity of a newborn screening method for severe combined immunodeficiency (SCID). The assay to be used is developed on the basis of PCR quantifi...
Detailed Description
To show that early diagnosis of SCID with a TREC screening assay can warrant timely treatment of the disease and avoid life-threatening infections on patients. Babies with SCID are unable to fight inf...
Eligibility Criteria
Inclusion
- Birth in a study hospital on the Navajo Reservation
Exclusion
- None
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT00845416
Start Date
March 1 2009
End Date
November 1 2011
Last Update
July 16 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinle Hospital
Chinle, Arizona, United States
2
Tuba City Hospital
Tuba City, Arizona, United States